Alector (ALEC) holds steady despite trial failures, pivoting to ABC platform and Roche deal extending cash to 2029.
"This will be the first of many," Musk said in a social media post.
Kodiak's Zenkuda shows promise across three retinal diseases, with positive phase III data and a planned 2026 regulatory filing.
The Chinese company says it will convert the manufacturing capacity at its base in Tianjin into its proprietary ...
AIKO Solar will convert 6 GW of PERC cell capacity at its Tianjin base to all back contact ABC technology in a CNY1.15 ...
EyePoint stock crashed 85% after Duravyu missed a Phase 3 wet AMD endpoint. Click here to read my most recent analysis of ...
Mark Zuckerberg spelled out the social media giant’s plans, which focus heavily on Muse, the company’s AI assistant.
Eli Lilly is growing quickly, lowering realized prices, and building its next wave of drugs. Here's what the numbers say ...
Target Price (Mid): ~$145Street Target: ~$127Potential Total Return: ~43%Annualized IRR: ~9% / yearWhat Happened?The Walt Disney Company (DIS:NYSE) closed at $101.
Hung Yen - More than 200 digital transformation ideas at ABC Vietnam Company, aiming to improve processes, save time and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results